Press Releases

MINNEAPOLIS, May 21, 2024 /PRNewswire/ -- Nystrom & Associates, a leading provider of behavioral health care services, today celebrated the expansion of its Hugo, Minn. clinic. The expansion will almost double the clinic's size and will enable more providers to meet the community's mental health care needs. It will also eventually allow the addition of medication management services, ensuring prescribed medications are used effectively and safely, and will incorporate... (continue reading...)

TEMPE, Ariz., May 21, 2024 /PRNewswire/ -- GoDaddy Inc. (NYSE: GDDY) today announced Go Daddy Operating Company, LLC and GD Finance Co, LLC (together with Go Daddy Operating Company, LLC, the "Borrowers") allocated a $1,000 million tranche (the "Replacement Term Loans") of term loans maturing in 2031, and in connection therewith, the Borrowers intend to refinance and extend the maturity date of all outstanding Tranche B-4 Loans and up to $278 million of outstanding... (continue reading...)

LAFAYETTE, Ind., May 21, 2024 (GLOBE NEWSWIRE) -- Wabash (NYSE: WNC) today announced that its board of directors declared a regular quarterly dividend of $0.08 per share of the company’s common stock, payable on July 25, 2024, to stockholders of record on July 3, 2024.

Wabash: Changing How the World Reaches YouAs the innovation leader of connected solutions for the transportation, logistics and distribution industries, Wabash (NYSE: WNC) is Changing How the... (continue reading...)

MIAMI, May 21, 2024 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the “Company”) (NYSE: PFLT) today announced that PennantPark Senior Secured Loan Fund I LLC (“PSSL”) through PSSL’s wholly-owned and consolidated subsidiary, PennantPark CLO II, Ltd (“CLO II”) has closed the refinancing of a four-year reinvestment period, twelve-year final maturity $300.7 million debt securitization in the form of a collateralized loan obligation (“CLO”).

May 8, 2024 — Boston, Mass. — hC Bioscience, a biopharmaceutical company developing a fundamentally novel approach to treating genetic diseases through tRNA-based protein editing, today presented preclinical data supporting its lead program in severe hemophilia A at the American Society of Gene and Cell Therapy Annual Meeting in Baltimore, Md.  

To view the full announcement, including downloadable images, bios, and more, click here.

• Preclinical data... (continue reading...)